SB 527Session 2026
Pharmaceutical Substance Manufacturing Grant Fund; created.
Progress
- Introduced
- In committee
- Passed Senate
- Passed legislature
- Sent to governor
- Became law
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
Approved by Governor-Chapter 809 (effective 7/1/2026)
-
Governor's Action Deadline 11:59 p.m., April 13, 2026
-
Senate
Enrolled Bill communicated to Governor on March 10, 2026
-
Senate
Signed by President
-
House
Signed by Speaker
-
Senate
Fiscal Impact Statement from Department of Planning and Budget (SB527)
-
Senate
Bill text as passed Senate and House (SB527ER)
-
Senate
Enrolled
-
House
Passed House (92-Y 6-N 0-A)
-
House
Read third time
-
House
Moved from Uncontested Calendar to Regular Calendar
-
House
Read second time
-
House
Reported from Appropriations (22-Y 0-N)
-
House
Assigned HAPP sub: Commerce Agriculture & Natural Resources
-
House
Referred to Committee on Appropriations
-
House
Read first time
-
House
Placed on Calendar
-
Senate
Read third time and passed Senate (39-Y 0-N 0-A)
-
Senate
Engrossed by Senate (Voice Vote)
-
Senate
Read second time
-
Senate
Passed by for the day Block Vote (Voice Vote)
-
Senate
Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
-
Senate
Rules suspended
-
Senate
Reported from Finance and Appropriations (14-Y 0-N)
-
Senate
Rereferred from Commerce and Labor to Finance and Appropriations (11-Y 0-N)
-
Senate
Fiscal Impact Statement from Department of Planning and Budget (SB527)
-
Senate
Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)
-
Senate
Referred to Committee on Education and Health
-
Senate
Prefiled and ordered printed; Offered 01-14-2026 26102905D